Akèy › Sipwa › Kalifòni › Santa Clarita

Etid klinik pou Sipwa nan Santa Clarita, CA

5 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Santa Clarita (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Ap rekriteFaz 3

California Medical Research Associates, Northridge · 11 mi lwen

Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ap rekriteFaz 3

California Medical Research Associates, Northridge · 11 mi lwen

Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Ap rekriteFaz 3

Care Access - Santa Clarita, Santa Clarita

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Ap rekriteFaz 4

Northridge Clinical Trials, Northridge · 11 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Ap rekriteFaz 3

Kailera Clinical Site, Northridge · 11 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901

Etid Sipwa nan lòt vil

Lòt etid nan Santa Clarita

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.